mapk activator scutebarbatine a (MedChemExpress)
MedChemExpress is a verified supplier 
MedChemExpress manufactures this product 
92
Structured Review
MedChemExpress
mapk activator scutebarbatine a
Mapk Activator Scutebarbatine A, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hy-n1260/Scutebarbatine+A/pm38267731-34-5-12
Average 92 stars, based on 1 article reviews
Mapk Activator Scutebarbatine A, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hy-n1260/Scutebarbatine+A/pm38267731-34-5-12
Average 92 stars, based on 1 article reviews
mapk activator scutebarbatine a - by Bioz Stars,
2026-10
92/100 stars
Images
Related Articles
Activation Assay:Article Title: Activation of CHPF by transcription factor NFIC promotes NLRP3 activation during the progression of colorectal cancer. Article Snippet: Given the role of chondroitin polymerizing factor (CHPF) in several cancers, we investigated its role in the progression of colorectal cancer (CRC) and its association with NLRP3 inflammasome activation.. High expression of CHPF in CRC predicted poor patient prognosis.. Using colony formation, EdU staining, wound healing, Transwell invasion, and flow cytometry assays, we revealed that the downregulation of CHPF inhibited the malignant behavior of CRC cells. Control:Article Title: Activation of CHPF by transcription factor NFIC promotes NLRP3 activation during the progression of colorectal cancer. Article Snippet: Given the role of chondroitin polymerizing factor (CHPF) in several cancers, we investigated its role in the progression of colorectal cancer (CRC) and its association with NLRP3 inflammasome activation.. High expression of CHPF in CRC predicted poor patient prognosis.. Using colony formation, EdU staining, wound healing, Transwell invasion, and flow cytometry assays, we revealed that the downregulation of CHPF inhibited the malignant behavior of CRC cells. |